Abstract | BACKGROUND: METHODS: We examined the ability of four novel 20-epi-vitamin D3 analogs (CB1093, KH1060, KH1266, and CB1267), either alone or in combination with 9-cis retinoic acid (RA) to inhibit colony growth of a human prostate cancer cell line, LNCaP, using soft agar as well as bone marrow stroma. Also, the effect of these analogs on the cell cycle and expression of Ki-67, p21(waf-1), and p27(kip1) in LNCaP cells was examined. RESULTS: The analog CB1267 was the most potent, with 8 x 10(-10) M of the analog inhibiting 50% colony growth (ED50) of LNCaP. 9-cis-RA also inhibited colony growth of LNCaP (ED50, 5 x 10(-7) M). Combined, CB1267 and 9-cis-RA synergistically inhibited colony growth and significantly increased the number of LNCaP cells in G0/G1 phase. Cell cycle arrest was associated with increased levels of p21(waf-1) and p27(kip1) and decreased expression of Ki-67 protein. Pulse-exposure to this combination (5 x 10(-8) M) irreversibly inhibited colony growth, both in soft agar and on normal human bone marrow stroma. CONCLUSIONS: Combination of a new vitamin D3 analog ( CB1267) and a retinoid (9-cis-RA) potently inhibited colony formation of LNCaP prostate cancer cells in vitro, suggesting further studies in animal models. This combination may afford an interesting therapeutic approach to low-burden prostate cancer.
|
Authors | E Elstner, M J Campbell, R Munker, P Shintaku, L Binderup, D Heber, J Said, H P Koeffler |
Journal | The Prostate
(Prostate)
Vol. 40
Issue 3
Pg. 141-9
(Aug 01 1999)
ISSN: 0270-4137 [Print] United States |
PMID | 10398275
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.)
|
Copyright | Copyright 1999 Wiley-Liss, Inc. |
Chemical References |
- Antineoplastic Agents
- CB 1093
- CB 1267
- CDKN1A protein, human
- Cell Cycle Proteins
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclins
- KH 1266
- Microtubule-Associated Proteins
- Tumor Suppressor Proteins
- KH 1060
- Cyclin-Dependent Kinase Inhibitor p27
- Alitretinoin
- Tretinoin
- Calcitriol
|
Topics |
- Alitretinoin
- Antineoplastic Agents
(toxicity)
- Bone Marrow Cells
(cytology)
- Calcitriol
(analogs & derivatives, toxicity)
- Cell Cycle
(drug effects)
- Cell Cycle Proteins
- Cell Division
(drug effects)
- Cell Survival
(drug effects)
- Cyclin-Dependent Kinase Inhibitor p21
- Cyclin-Dependent Kinase Inhibitor p27
- Cyclins
(metabolism)
- Drug Synergism
- Humans
- Male
- Microtubule-Associated Proteins
(metabolism)
- Prostatic Neoplasms
- Stromal Cells
(cytology, drug effects)
- Tretinoin
(toxicity)
- Tumor Cells, Cultured
- Tumor Suppressor Proteins
|